Reports and presentations

Skip to content

Contact us
Newsroom
- Our locations
  
  Australia
  
  Austria
  
  Belgium nl fr
  
  China
  
  Czech Republic
  
  Denmark
  
  Estonia
  
  Finland fi en
  
  France
  
  Germany
  
  Greece
  
  Hungary
  
  India
  
  Ireland
  
  Italy
  
  Japan
  
  Kazakhstan ru kz
  
  Latvia
  
  Lithuania
  
  Malaysia
  
  Netherlands
  
  Norway
  
  Poland
  
  Singapore
  
  Slovenia
  
  Spain
  
  Sweden
  
  Switzerland
  
  Thailand
  
  UK
  
  Ukraine
Visit global site 

What are you looking for?

Quick links

Careers at Orion

About Orion Pharma
To main page of

About Orion Pharma
Science & Innovation
To main page of

Science & Innovation
Therapy areas
To main page of

Therapy areas
Partnering
To main page of

Partnering
Investors
To main page of

Investors
Careers
To main page of

Careers

About Orion Pharma
Science & Innovation
Therapy areas
Partnering
Investors
Careers
Contact us
Newsroom

Highlights 2025
Orion as an investment
- Strategy and purpose
Reports and presentations
Financial information
Share information
Shareholders
Corporate Governance
IR Calendar
Investor Relations

Start page  Investors  Reports and presentations

Highlights 2025
Orion as an investment
- Strategy and purpose
Reports and presentations
Financial information
Share information
Shareholders
Corporate Governance
IR Calendar
Investor Relations

Interim Report for January–September 2026

Orion published Interim Report for January–September 2026 on Wednesday, 28 October 2026.

CEO's review

CEO's review 

Latest financial release

Orion Interim Report Q3 2026 
Orion results presentation Q3 2026 
Investor presentation Q3 2026 
Webcast 

Results webcast

Reports and presentations

Financial reports

Annual Reports

Outlook for 2026

About us
Science
Therapy areas
Products
Partnering
Investors
Careers
Contact us

Orion Corporation, Orionintie 1A, 02200 Espoo.
PO Box 65, FI-02101 Espoo, Finland
Phone +358 10 4261

© Copyright Orion Corporation. Company code, VAT 19992126

About us
Science
Therapy areas
Products
Partnering
Investors
Careers at Orion

Contact us
Newsroom
Orion Pharma brand

Privacy
Site terms
Cookie Policy